Yerepouni Daily News
No Result
View All Result
  • Հայերէն Լուրեր
  • Յօդուածներ
  • Հարցազրոյցներ
  • Մարզական
  • Այլազան
    • Զանազանք
    • Մշակութային
    • Գաղութահայ Կեանք
  • Արեւելահայերէն Լուրեր
  • English
    • World News
      • Africa
      • America
      • Asia
      • Australia
      • Europe
      • Middle East
    • Markets & Economy
    • International Press
    • Health
    • Social
    • Sports
    • Art & Entertainment
    • Science & Technology
  • أخبار باللغة العربية
  • Հայերէն Լուրեր
  • Յօդուածներ
  • Հարցազրոյցներ
  • Մարզական
  • Այլազան
    • Զանազանք
    • Մշակութային
    • Գաղութահայ Կեանք
  • Արեւելահայերէն Լուրեր
  • English
    • World News
      • Africa
      • America
      • Asia
      • Australia
      • Europe
      • Middle East
    • Markets & Economy
    • International Press
    • Health
    • Social
    • Sports
    • Art & Entertainment
    • Science & Technology
  • أخبار باللغة العربية
No Result
View All Result
Yerepouni Daily News
No Result
View All Result

No need yet to adapt Pfizer vaccine for COVID variants: BioNTech chief

August 10, 2021
in World News, Europe
0
Turkey increases daily COVID-19 vaccinations to record 842,494

The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said on Aug. 9.

“It is quite possible that in the next six to 12 months, further variants will emerge and that would require adaptation of the vaccine but it is at the moment not yet the case,” Uğur Şahin told journalists.

A decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection against the virus.

The fast-changing situation meant that getting the timing for the change right was also crucial.

“Making a decision at the moment might turn out to be wrong in three or six months if another variant is dominating. Therefore the timing of the decision must be appropriate,” he said.

“At the moment we have a good understanding that the booster vaccine with the parental strain is completely sufficient,” stressed Şahin.

BioNTech’s partner Pfizer has also repeatedly amplified the case for booster shots amid the latest wave of infections.
Countries including France and Germany have said they will begin offering the additional shot to the elderly and the most vulnerable from September.

BioNTech-Pfizer have shipped around one billion doses of their vaccines to more than 100 countries or territories around the world.

They are expecting their annual manufacturing capacity to reach three billion doses by year’s end, before climbing to four billion doses in 2022.

Hurriyet Daily News

Previous Post

Լաւրով Եւ Պայրամով Քննեցին Հայ-ատրպէյճանական Սահմանի Իրավիճակը

Next Post

Քոնրատ Լորենցի Հետ Անմիջականէն Անդին` Մտածել Քաղաքակրթութեան Մեղանչումի Մասին

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About Us
  • Contact Us

© 2021 Yerepouni News - Website by Alienative.net.

No Result
View All Result
  • Հայերէն Լուրեր
  • Յօդուածներ
  • Հարցազրոյցներ
  • Մարզական
  • Այլազան
    • Զանազանք
    • Մշակութային
    • Գաղութահայ Կեանք
  • Արեւելահայերէն Լուրեր
  • English
    • World News
      • Africa
      • America
      • Asia
      • Australia
      • Europe
      • Middle East
    • Markets & Economy
    • International Press
    • Health
    • Social
    • Sports
    • Art & Entertainment
    • Science & Technology
  • أخبار باللغة العربية

© 2021 Yerepouni News - Website by Alienative.net.